Efficacy of lycopene in the management of oral submucous fibrosis

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology

Volumn 103, Issue 2, 2007, Pages 207-213

  Kumar, Abhinav ^a   Bagewadi, Anjana ^a   Keluskar, Vaishali ^a   Singh, Mohitpal ^b  

^a Department of Oral Medicine and Radiodiagnosis ^*  (India)

^b Reader   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIOXIDANT; BETAMETHASONE; CAROTENOID; LYCOPENE;

ADULT; AGED; ARTICLE; BETEL NUT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; JOINT CHARACTERISTICS AND FUNCTIONS; MALE; MIDDLE AGED; MOUTH DISEASE; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; ARECA; BETAMETHASONE; CAROTENOIDS; HUMANS; MALE; MIDDLE AGED; ORAL SUBMUCOUS FIBROSIS; RANGE OF MOTION, ARTICULAR;

EID: 33846242615     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tripleo.2006.07.011     Document Type: Article

References (16)

1. Canniff J.P., and Harvey W. The aetiology of oral submucous fibrosis: the stimulation of collagen synthesis by extracts of areca nut. Int J Oral Surg 10 suppl 1 (1981) 163-167
2. Harvey W., Scutt A., Meghji S., and Canniff J.P. Stimulation of human buccal mucosa fibroblasts in vitro by betel-nut alkaloids. Arch Oral Biol 31 1 (1986) 45-49
3. Maher R., Lee A.J., Warnakulasuriya K.A., Lewis J.A., and Johnson N.W. Role of areca nut in the causation of oral submucous fibrosis: a case-control study in Pakistan. J Oral Pathol Med 23 (1994) 65-69
4. Canniff J.P., Harvey W., and Harris M. Oral submucous fibrosis: its pathogenesis and management. Br Dent J 160 (1986) 429-434
5. Gerster H. The potential role of lycopene for human health. J Am Coll Nutr 16 2 (1997) 109-126
6. Paiva S.A., and Russell R.M. Beta-carotene and other carotenoids as antioxidants. J Am Coll Nutr 18 5 (1999) 426-433
7. Singh M., Krishanappa R., Bagewadi A., and Keluskar V. Efficacy of oral lycopene in the treatment of oral leukoplakia. Oral Oncol 40 (2004) 591-596
8. Di Mascio P., Kairer S., and Sies H. Lycopene as the most efficient biological carotenoid singlet oxygen quencher. Arch Biochem Biophys 274 2 (1989) 532-538
9. Kitade Y., Watanabe S., Masaki T., Nishioka M., and Nishino H. Inhibition of liver fibrosis in LEC rats by a carotenoid, lycopene or a herbal medicine, Sho-saiko-to. Hepatology Research 22 (2002) 196-205
10. Maher R., Aga P., Johnson N.W., Sankaranarayanan R., and Warnakulasuriya S. Evaluation of multiple micronutrient supplementation in the management of oral submucous fibrosis in Karachi, Pakistan. Nutr Cancer 27 1 (1997) 41-47
11. Borle R.M., and Borle S.M. Management of oral submucous fibrosis: a conservative approach. J Oral Maxillofac Surg 49 (1991) 788-791
12. Nir Z., and Hartal D. Tomato lycopene the phytonutrient of the new millennium. Food Industry Journal 3 3 (2000) 208-219
13. Lai D.R., Chen H.R., Lin L.M., Huang Y.L., and Tsai C.C. Clinical evaluation of different treatment methods for oral submucous fibrosis. A 10-year experience with 150 cases. J Oral Pathol Med 24 (1995) 402-406
14. Landtwing K. Evaluation of the normal range of vertical mandibular opening in children and adolescents with special reference to age and stature. J Maxillofac Surg 6 (1978) 157-162
15. Haque M.F., Meghji S., Nazir R., and Harris M. Interferon gamma (IFN-γ) may reverse oral submucous fibrosis. J. Oral Pathol Med 30 (2001) 12-21
16. Heber D., and Lu Q.-Y. Overview of mechanisms of action of lycopene. Exp Biol Med 227 (2002) 920-923